EssilorLuxottica acquires Cellview for advanced retinal imaging technology
Deal News | Feb 11, 2025 | Globenewswire
EssilorLuxottica, a leader in the ophthalmic optics industry, has announced its acquisition of Cellview Imaging Inc., a Toronto-based med-tech startup specializing in advanced retinal imaging technology. The acquisition aligns with EssilorLuxottica’s strategy to enhance healthcare standards and expand its med-tech portfolio. Cellview's innovative ultra-widefield camera technology allows for high-resolution retinal images, aiding in efficient diagnosis of retinal diseases. The technology has received approvals from the FDA and CE, allowing it to serve eye care markets across North America and Europe. This strategic move aims to integrate Cellview’s research-driven solutions into EssilorLuxottica’s offerings, fulfilling the increasing demand for advanced eye care technologies and early retinal disease detection capabilities. According to EssilorLuxottica’s leadership, this acquisition will complement their open business model and commitment to market growth in med-tech.
Sectors
- Medical Technology
- Optics and Eyewear
Geography
- Canada – The acquisition target, Cellview, is based in Toronto, Canada, making it a key geographic location.
- France – EssilorLuxottica is headquartered in France, where the acquisition deal was announced.
- North America – Cellview's products are currently distributed in North America, key for market expansion.
- Europe – EssilorLuxottica plans to distribute Cellview's solutions in Europe, marking it as a future target geography.
Industry
- Medical Technology – Cellview specializes in med-tech for advanced retinal imaging, positioning EssilorLuxottica in the medical technology market.
- Optics and Eyewear – EssilorLuxottica operates in the optics and eyewear sector, expanding its offerings through the acquisition of advanced imaging technology.
Financials
- – The financial terms of the acquisition have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EssilorLuxottica | Acquiring Company | Company | A leading company in the ophthalmic optics and eyewear industry, aiming to expand its med-tech portfolio. |
| Cellview Imaging Inc. | Target Company | Company | A Canadian startup specializing in advanced retinal imaging technology with innovative ultra-widefield cameras. |
| Francesco Milleri | President and CEO of EssilorLuxottica | Person | He oversees strategic decisions and acquisition integration at EssilorLuxottica. |
| Paul du Saillant | Deputy CEO of EssilorLuxottica | Person | He plays a key role in strategic direction and management at EssilorLuxottica. |